ING Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
U
CS
ING Group's XBI Position: Q2 2014 in Review
ING Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2014, closing a stake of 53,031 shares — an estimated $2.52M sold.
ING Group first reported a position in XBI in Q2 2013 and held it in 2 quarters. The position peaked at $17.5M in Q2 2013. 123 funds tracked by Wall St. Rank hold XBI as of Q2 2014.
- ING Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2014 after selling out during the quarter.
- ING Group sold 53,031 State Street SPDR S&P Biotech ETF shares in Q2 2014, an estimated $2.52M.
- ING Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and held it in 2 quarters.
- ING Group's State Street SPDR S&P Biotech ETF position peaked at $17.5M in Q2 2013.
- 123 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2014.
Based on ING Group's 13F filing for Q2 2014, filed 14 Aug 2014.